Dedicated Denville Depo-Provera Class Action Attorneys Representing Injured Patients Across Morris County and Northern New Jersey
Depo-Provera has been widely prescribed as a long-acting injectable birth control medication. While many patients rely on it for pregnancy prevention, growing concerns have emerged about serious side effects that were not adequately disclosed to users before receiving injections.
Women across the country allege that they were not adequately warned about long-term risks, potential complications, and the impact Depo-Provera may have on their health. A number of lawsuits have been filed by women who developed meningioma brain tumors after using Depo-Provera, raising urgent questions about whether the drug’s manufacturer concealed known tumor-related risks from patients and physicians.
When drug manufacturers fail to disclose known dangers or minimize risks in marketing materials, the law allows injured patients to seek accountability.
At the Law Offices of G. Martin Meyers, our Denville Depo-Provera class action attorneys represent women harmed by undisclosed risks involving this medication. We help clients pursue financial compensation and hold pharmaceutical companies accountable for failing to protect patients.
Understanding the Risks of Depo-Provera
Depo-Provera is administered via injection, typically every three months. The medication works by preventing ovulation and altering hormone levels. However, many patients have reported serious complications after long-term use.
Allegations in lawsuits and investigations often involve:
- Meningioma brain tumors and other intracranial tumor growth.
- Bone density loss and osteoporosis.
- Fractures are associated with reduced bone strength.
- Persistent hormonal changes or long-term menstrual problems.
- Neurological or autoimmune symptoms reported after injections.
- Inadequate warnings regarding long-term effects.
Some women say they would have chosen a different birth control method if they had been fully informed about these potential risks before receiving Depo-Provera.
Depo-Provera and Meningioma Brain Tumors
Much of the emerging research and litigation involving Depo-Provera focuses on the link between use of the drug and the development of a kind of brain tumor known as meningioma. Meningiomas are typically slow-growing tumors that form in the membranes surrounding the brain and spinal cord. Although frequently benign, they can cause serious neurological symptoms, require surgical removal, and lead to permanent impairment.
Lawsuits allege that prolonged exposure to high-dose synthetic progestins in Depo-Provera may stimulate abnormal tumor growth, increasing the risk of meningiomas, particularly with long-term or repeated injections. Many women report being diagnosed with meningioma only after years of Depo-Provera use, without ever being warned that brain tumors were a potential risk.
For many patients, a meningioma diagnosis results in brain surgery, radiation therapy, long-term monitoring, and lasting neurological complications. Plaintiffs argue they would never have chosen Depo-Provera had they been informed that use of the drug could increase the risk of developing a brain tumor.
Depo-Provera Mass Tort Litigation
Drug manufacturers have a legal duty to thoroughly test medications and disclose known dangers to doctors and patients. When they fail to do so, the harm often affects large groups of people across the country in similar ways.
Multi-district litigation allows the federal courts to consolidate related mass tort litigation into one proceeding to allow victims to pursue justice collectively. The federal courts have consolidated thousands of cases alleging that the use of Depo-Provera caused women to develop meningioma into one proceeding in Florida.
These types of lawsuits seek to recover for:
- Medical costs and treatment.
- Loss of income or diminished ability to work.
- Pain and suffering.
- Ongoing monitoring or long-term care related to complications.
By combining claims, plaintiffs gain a stronger voice against large pharmaceutical companies with significant legal resources.
Did The Manufacturer Fail to Warn Patients?
A central issue in these cases is whether the manufacturer provided sufficient warnings about the long-term risks of using Depo-Provera.
Plaintiffs allege that the company:
- Failed to disclose the risk that long-term use of Depo-Provera can cause the development of meningioma brain tumors.
- Downplayed or minimized these risks in marketing materials.
- Did not provide adequate long-term safety information.
- Did not update warnings as more data became available.
- Did not use a safer form of the drug available to patients in Europe.
Plaintiffs allege that the manufacturers knew about the evidence linking Depo-Provera to meningioma brain tumors but failed to disclose that information, despite mounting scientific evidence suggesting a causal connection between progestin-based drugs like Depo-Provera and the development of tumors. Plaintiffs further allege that the lack of any warnings about the risk of brain tumors prevented patients and physicians from properly weighing the risks of long-term use of the medication.
Failure to warn is a recognized legal theory in pharmaceutical litigation. If manufacturers knew, or should have known, about risks and failed to disclose them, they may be held responsible.
Who May Qualify for a Depo-Provera Claim
You may be eligible to pursue compensation if you used Depo-Provera and later experienced complications such as:
- Diagnosis of meningioma or other brain tumors following Depo-Provera use.
- Osteoporosis or significant bone loss.
- Fractures without significant trauma.
- Chronic pain is associated with bone weakening.
- Hormonal complications that persist after stopping the injections.
- Serious health changes that your doctor suspects are connected to Depo-Provera.
Eligibility depends on medical history, documentation, length of use, and the nature of your injuries. Our team conducts thorough evaluations and works with medical professionals to gain a comprehensive understanding of your circumstances.
How Our Denville Depo-Provera Attorneys Help
Pharmaceutical litigation is complex and highly technical.
Our firm guides clients through every step by:
- Reviewing medical records and history.
- Determining whether your case should be filed with the multi-district litigation in Florida or in state court.
- Working with medical experts to evaluate injury links.
- Pursuing compensation through negotiations or litigation.
We are committed to ensuring that injured patients have access to skilled advocacy and a clear understanding of their rights.
Speak With Our Depo-Provera Class Action Attorneys in Denville
If you believe Depo-Provera may have caused serious health complications, you do not have to face this alone. The Law Offices of G. Martin Meyers is ready to help women in Denville, Morris County, and northern New Jersey who are considering a lawsuit related to their use of Depo-Provera.
Call (973) 625-0838 or contact us online to schedule a free consultation. We will review your situation and explain your legal options.
(973) 625-0838 
